Menard Financial Group’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4
Closed -$2.12K 129
2024
Q4
$2.12K Buy
+4
New +$2.25K ﹤0.01% 280
2023
Q2
Sell
-435
Closed -$234K 71
2023
Q1
$234K Sell
435
-113
-21% -$57.6K 0.54% 52
2022
Q4
$280K Buy
548
+35
+7% +$17K 0.67% 44
2022
Q3
$224K Sell
513
-35
-6% -$16.8K 0.41% 71
2022
Q2
$257K Sell
548
-170
-24% -$82.9K 0.42% 67
2022
Q1
$364K Buy
718
+180
+33% +$86.3K 0.36% 90
2021
Q4
$285K Buy
+538
New +$258K 0.23% 114

Other funds holding CHE

Menard Financial Group's CHE Position: Q1 2025 in Review

Menard Financial Group sold out of Chemed (CHE) in Q1 2025, closing a stake of 4 shares — an estimated $2.12K sold.

Menard Financial Group first reported a position in CHE in Q4 2021 and held it in 7 quarters. The position peaked at $364K in Q1 2022. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • Menard Financial Group reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 4 Chemed shares in Q1 2025, an estimated $2.12K.
  • Menard Financial Group first reported a position in Chemed in Q4 2021 and held it in 7 quarters.
  • Menard Financial Group's Chemed position peaked at $364K in Q1 2022.
  • 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.